Can we predict for missed clinically significant prostate cancers on MRI-Targeted biopsy alone?

被引：0
|
作者：
Tsang, W. C. [1 ]
Wang, K. [1 ]
Quek, A. J. Y. [1 ]
Wang, Z. [1 ]
Chiong, E. [2 ]
Wu, Q. [1 ]
机构：
[1] Natl Univ Singapore Hosp, Dept Urol, Singapore, Singapore
[2] Natl Univ Singapore, Dept Surg, Singapore, Singapore
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0174
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [21] Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers
    Parra, Nestor Andres
    Lu, Hong
    Choi, Jung
    Gage, Kenneth
    Pow-Sang, Julio
    Willies, Robert J.
    Balagurunathan, Yoganand
    TOMOGRAPHY, 2019, 5 (01) : 68 - 76
  • [22] Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
    Drost, Frank-Jan H.
    Osses, Daniel F.
    Nieboer, Daan
    Steyerberg, Ewout W.
    Bangma, Chris H.
    Roobol, Monique J.
    Schoots, Ivo G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (04):
  • [23] MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
    Eklund, Martin
    Jaderling, Fredrik
    Discacciati, Andrea
    Bergman, Martin
    Annerstedt, Magnus
    Aly, Markus
    Glaessgen, Axel
    Carlsson, Stefan
    Groenberg, Henrik
    Nordstroem, Tobias
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 908 - 920
  • [24] Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy
    Bjurlin, Marc A.
    Taneja, Samir S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (04) : 535 - +
  • [25] Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy
    Coker, Michael Austin
    Glaser, Zachary A.
    Gordetsky, Jennifer B.
    Thomas, John, V
    Rais-Bahrami, Soroush
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (04) : 549 - 555
  • [26] IMPACT OF PROSTATE IMAGING QUALITY (PI-QUAL) SCORE ON THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN UNDERGOING MRI-TARGETED BIOPSY
    Brembilla, Giorgio
    Lavalle, Salvatore
    Cosenza, Michele
    Russo, Tommaso
    Sorce, Gabriele
    Pellegrino, Francesco
    Robesti, Daniele
    Pellegrino, Antony
    Longoni, Mattia
    Scilipoti, Pietro
    Zaurito, Paolo
    Quarta, Leonardo
    Mazzone, Elio
    Stabile, Armando
    Grubmuller, Bernhard
    Shariat, Shahrok
    Esposito, Antonio
    Gandaglia, Giorgio
    Francesco, De Cobelli
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E1048 - E1049
  • [27] EVALUATION OF TRANSITIONAL ZONE LESIONS ON MULTIPARAMETRIC MRI AND MRI-TARGETED BIOPSY IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE COMMUNITY SETTING: A RETROSPECTIVE STUDY
    Taylor, Zachariah
    Belkoff, Laurence
    Buckholtz, Caroline
    Gibb, Oliver
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S101 - S102
  • [28] A critical comparison of techniques for MRI-targeted biopsy of the prostate
    Giganti, Francesco
    Moore, Caroline M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (03) : 432 - 443
  • [29] Impact of Prostate Imaging Quality (PI-QUAL) score on the detection of clinically significant prostate cancer in men undergoing MRI-targeted biopsy
    Brembilla, G.
    Gandaglia, G.
    Stabile, A.
    Mazzone, E.
    Sorce, G.
    Pellegrino, F.
    Robesti, D.
    Pellegrino, A.
    Longoni, M.
    Scilipoti, P.
    Quarta, L.
    Zaurito, P.
    Di Gaeta, E.
    Lavalle, S.
    Cosenza, M.
    Montorsi, F.
    Briganti, A.
    Esposito, A.
    De Cobelli, F.
    EUROPEAN UROLOGY, 2023, 83
  • [30] Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy
    Michael Austin Coker
    Zachary A. Glaser
    Jennifer B. Gordetsky
    John V. Thomas
    Soroush Rais-Bahrami
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 549 - 555
12345